Omaxe Q3 FY26 results: standalone revenue up 44% YoY, consolidated loss narrows
OMAXE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.6 pts less than Nifty Microcap 250 and 1.8 pts less than its Residential Commercial Projects peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Omaxe Limited reported Q3 FY26 standalone revenue of Rs 109.18 cr, up about 44% YoY from Rs 76.03 cr. Standalone net loss narrowed to Rs 26.24 cr from Rs 40.30 cr. For 9M FY26, consolidated revenue fell about 11% to Rs 904.88 cr, but consolidated net loss narrowed to Rs 505.39 cr from Rs 536.73 cr. Standalone other equity is negative at about Rs 388 cr. Auditors flagged a SEBI order from July 2024 as emphasis of matter, with SAT hearing due March 24, 2026.
Losses persist but are narrowing on standalone. Negative other equity and ongoing SEBI litigation remain key risks for shareholders.